Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI
Mirum Pharmaceuticals will be hosting an investor call to present the topline results from the Phase 3 EXPAND Study of LIVMARLI.
"Business Wire" reports on this upcoming event.